EPISODE · Mar 11, 2024 · 37 MIN
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
from Oncology Today with Dr Neil Love
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York City discusses available and emerging data with oral SERDs for patients with ER-positive metastatic breast cancer. CME information and select publications here.
Embed this episode
Ready to play
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
0:00
37:38
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Today with Dr Neil Love?
This episode is 37 minutes long.
When was this Oncology Today with Dr Neil Love episode published?
This episode was published on March 11, 2024.
Can I download this Oncology Today with Dr Neil Love episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!